Kura Oncology, Inc is a San Diego-based biopharmaceutical company dedicated to realizing the potential of precision medicines in improving the lives of cancer patients. Their innovative therapies are designed to selectively target cancer cells, increasing clinical benefits and addressing the most pressing unmet needs in areas such as head and neck cancer, lung cancer, and acute leukemias. Committed to advancing the field, Kura Oncology also explores combination therapies with standard treatments to provide patients with better chances of long-term durable remissions.
Driven by a culture of scientific innovation and courage, Kura Oncology's team of dedicated professionals works together to create new possibilities for patients. They are guided by a deep understanding of the molecular processes driving cancer, pioneering new approaches to treat devastating diseases. With a focus on improving patient outcomes and expanding access to effective cancer therapeutics, Kura Oncology is at the forefront of precision oncology, bringing hope and progress to those affected by cancer.
Generated from the website